We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Quotient Clinical Celebrates its 100th RapidFACT® Program
News

Quotient Clinical Celebrates its 100th RapidFACT® Program

Quotient Clinical Celebrates its 100th RapidFACT® Program
News

Quotient Clinical Celebrates its 100th RapidFACT® Program

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Quotient Clinical Celebrates its 100th RapidFACT® Program"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

RapidFACT has been proven to accelerate drug formulation development for all routes of delivery, and over 50 leading pharmaceutical and biotech companies globally have now adopted this approach.

RapidFACT can reduce development timelines by at least 50 % while delivering significant cost savings. This is achieved through Quotient Clinical’s innovative Translational Pharmaceutics platform, which integrates formulation development, GMP manufacturing and clinical testing in one location, allowing the product to be adapted in real-time, based on emerging clinical data. This approach has already been successfully used in programs focused on evaluating solubilisation technologies, optimising modified release systems, changing routes of delivery and developing combination products, with over 300 different formulation prototypes studied to date.

John McDermott, Executive Director of Drug Product Optimisation at Quotient Clinical, commented: “RapidFACT was launched in response to the challenges our customers faced in their development pipelines. We are delighted to announce our 100th program as confirmation of our ability to shorten timelines and save costs in the reformulation and optimisation of drug products. Ultimately, this approach is helping our customers to address many of the R&D productivity issues prevalent in the industry today.”

Advertisement